CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ekbom, A.
Right arrow Articles by Hsieh, C.-c.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ekbom, A.
Right arrow Articles by Hsieh, C.-c.
Cancer Epidemiology Biomarkers & Prevention Vol. 9, 221-223, February 2000
© 2000 American Association for Cancer Research


Short Communications

Duration of Gestation and Prostate Cancer Risk in Offspring1

Anders Ekbom, Joanne Wuu, Hans-Olov Adami, Chih-Ming Lu, Pagona Lagiou, Dimitrios Trichopoulos and Chung-cheng Hsieh2

Department of Medical Epidemiology, Karolinska Institute, Stockholm S-171 77, Sweden [A. E., H-O. A.]; University of Massachusetts Cancer Center, Worcester, Massachusetts 01605 [J. W., C-M. L., C-c. H.]; Department of Urology, Tian-Sheng Memorial Hospital, Pingtung 928, Taiwan [C-M. L.]; Department of Epidemiology, Harvard School of Public Health and Harvard Center for Cancer Prevention, Boston, Massachusetts 02115 [D. T., C-c. H.]; and University of Athens, Athens 115 27, Greece [P. L., D. T.]

This large population-based nested case-control study investigated the importance of perinatal characteristics as risk factors for prostate cancer in later life in a cohort of men who were born between 1889 and 1941 in Stockholm, Sweden. Eight hundred and thirty-four prostate cancer cases over 18 years of age and of singleton birth were identified from the cohort between 1958 and 1994. For each case, singleton males born live to the first four mothers admitted after the case’s mother were selected as potential controls; 1880 eligible controls were included in the study. For each study subject, we obtained data on mother’s parity, pre-eclampsia or eclampsia before delivery, age at delivery, and socioeconomic status, as well as child’s birth length and weight, placental weight, and gestational age. Odds ratio (OR) estimates and 95% confidence intervals (CIs) were derived from logistic regression analyses. We found no statistically significant differences between cases and controls with respect to maternal age, socioeconomic status, or parity. Birth weight, birth length, and placental weight were also not significantly related to prostate cancer risk. Pregnancy toxemia (OR = 0.33; 95% CI, 0.07–1.45) and longer gestation age were associated with a reduced risk of prostate cancer; the OR estimate was 0.94 (95% CI, 0.89–0.99) for each 1-week prolongation of the duration of gestation. Our results suggest that birth size indicators are not important risk factors for prostate cancer in later life. In addition, our data on gestation age indicate that the late in utero environment may be as important as the early in utero environment in the modulation of prostate cancer risk in offspring.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.